Article metrics

Download PDFPDF

Original research
Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison

 

Online download statistics by month:

Online download statistics by month: May 2020 to June 2024

AbstractFullPdf
May 20202092247133
Jun 202020119884
Jul 2020666621
Aug 2020756328
Sep 2020938725
Oct 2020757328
Nov 2020777535
Dec 2020837530
Jan 2021706519
Feb 2021726721
Mar 2021655633
Apr 20211049640
May 2021867645
Jun 2021746745
Jul 2021675837
Aug 2021594433
Sep 2021705037
Oct 2021715051
Nov 2021594951
Dec 2021645529
Jan 2022726933
Feb 2022484425
Mar 2022656029
Apr 2022575136
May 2022565625
Jun 202211210232
Jul 2022524930
Aug 2022777024
Sep 2022786739
Oct 2022857227
Nov 2022626037
Dec 2022413512
Jan 2023655814
Feb 2023685624
Mar 2023594836
Apr 2023393524
May 2023666140
Jun 2023575219
Jul 2023282424
Aug 2023413712
Sep 2023594914
Oct 2023827414
Nov 2023645318
Dec 2023464518
Jan 2024634828
Feb 2024716029
Mar 2024857368
Apr 2024949542
May 2024756338
Jun 2024948334
Total558433661670